Peptide Record

BPC-157 · Immune · graded 2026-07-30

Inflammation

This grade describes how much evidence exists for BPC-157 against inflammation — not whether it works, and not whether it is safe. It is computed from the inputs below by a fixed rule with no editorial adjustment.

Why this grade

Not hidden behind a control — showing the work is the point
Score decomposition — every input and its contribution
ComponentPointsScale
Best study type
The strongest design that produced evidence for this outcome, not the average design.
+2Human RCT 5 · Human observational 4 · Animal 2 · Preclinical 1 · None 0
Largest human sample
Largest single human study, not a pooled total across studies.
0n ≥ 200 → 3 · 50–199 → 2 · < 50 → 1 · no human study → 0
Independent replication
Distinct research groups at the best study tier above, resolved through author and institution records.
+2≥ 3 groups → 3 · 2 → 2 · 1 → 1 · 0 → 0
Directional consistency
Share of studies at the best study tier reporting effect in the same direction — the same studies the replication row counts, not every record on the pair.
Measured over 2 stated directions across 3 studies at the best tier. A ratio over three readings and the same ratio over ninety are the same number and are not the same evidence.
0≥ 90% concordant → 3 · ≥ 70% → 2 · ≥ 50% → 1 · below → 0 · fewer than 3 readings → 0
Bias risk
A deduction, never a bonus. A flag is counted only where a record states one; silence is not a pass and is not a flag.
0−1 per flag, floor −3: industry funding · no preregistration · no blinding
Total4Sum of the rows above, floored at 0.
What the bias row had to work with — how many of this pair’s records disclosed each field at all
FieldFlag statedStated the oppositeNot statedSilent
industry_funded
industry-funded deducts a point; declared non-commercial does not; silence does neither.
004100%
preregistered
not preregistered deducts a point; preregistered does not; silence does neither.
004100%
blinded
not blinded deducts a point; blinded does not; silence does neither.
004100%

Grade A additionally requires a total of at least 11 and replication of at least 2: a high score carried by one research group is not replicated evidence, however large the trial.

Doses administered in studies

Sourced figures, not a protocol

Studied doses — not yet collected

Dose, route and n are extracted from study full text, and full text is paywalled for most records in this corpus. No dose has been extracted for this pair yet. Read that as an extraction gap, not as evidence that the studies below administered nothing.

This is a gap in our collection, not a finding about studied doses. Read it as “we have not looked yet”, never as “there is nothing there”. How extraction works and where it fails

Cited sources

4 records · ordered by source hierarchy

These are the records the grade above was computed from — the same set, by the same rule, read from one definition shared with the grader. Records attributed to an alias for a materially different product are not among them; where this pair has any, they are listed separately below.

  • ANIMAL3
  • PRECLINICAL1
SourceStudyDesignnBias flagsDate
ANIMALProtective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury.
PMID 40005408 · DOI 10.3390/medicina61020291 · matched on "BPC 157"
animalnone stated2025-02-08
ANIMALStable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation.
PMID 30690000 · DOI 10.1016/j.ejphar.2019.01.030 · matched on "BPC 157"
animalnone stated2019-03-15
ANIMALAntiinflammatory effect of BPC 157 on experimental periodontitis in rats.
PMID 20388954 · matched on "BPC 157"
animalnone stated2009-12-01
PRECLINICALA new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC.
PMID 8298609 · DOI 10.1016/0928-4257(93)90038-u · matched on "BPC 157"
not determinednone stated1993-01-01

Rows are ordered by source hierarchy, so nothing below a regulatory filing appears above a human trial. A field marked uncertain is one where the extraction passes disagreed; it publishes as unknown rather than as a picked winner. A design reading “not determined” is a design nothing established, not a design of none. Explore the full corpus for BPC-157